✦ LIBER ✦

Differences in symptoms between patients with benign and malignant ovarian neoplasms

✍ Scribed by Cara A Attanucci; Harrison G Ball; Susan L Zweizig; Annette H Chen

Book ID: 113427588
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 99 KB
Volume: 190
Category: Article
ISSN: 1097-6868
DOI: 10.1016/j.ajog.2004.01.077

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Differences in glycosylation of intracel

Differences in glycosylation of intracellular proteins between benign and malignant thyroid neoplasms

✍ A Krześlak; L Pomorski; Z Gaj; A Lipińska 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 258 KB

Lipids in serum of patients with maligna

Lipids in serum of patients with malignant ovarian neoplasms

✍ H. Gadomska; J. Janecki; L. Marianowski; G. Nowicka 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 515 KB

Differences inp16Gene Methylation and Ex

Differences inp16Gene Methylation and Expression in Benign and Malignant Ovarian Tumors

✍ Lisa L McCluskey; Chen Chen; Erika Delgadillo; Juan C Felix; Laila I Muderspach; 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 181 KB

Differences in tetranectin immunoreactiv

Differences in tetranectin immunoreactivity between benign and malignant breast tissue

✍ L. Christensen; I. Clemmensen 📂 Article 📅 1991 🏛 Springer 🌐 English ⚖ 937 KB

Tetranectin (TN) is a human, plasminogen kringle 4 binding plasma protein with ubiquitous cellular distribution and lectin-like characteristics. By means of the peroxidase-antiperoxidase staining technique a polyclonal and a monoclonal antibody were used to demonstrate TN within the intracellular as

Stathmin Immunoreactivity in Phaeochromo

Stathmin Immunoreactivity in Phaeochromocytomas and Paragangliomas: Differential Expression Between Benign and Malignant Neoplasms

✍ Wei-Chou Lin; Shyh-Chyan Chen; Yuan-Ting Chuang; Kuan-Lin Kuo; Kuo-How Huang 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 994 KB

CD44 expression in benign, premalignant,

CD44 expression in benign, premalignant, and malignant ovarian neoplasms: relation to tumour development and progression

✍ Saegusa, Makoto; Machida, Daisuke; Hashimura, Miki; Okayasu, Isao 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 484 KB 👁 2 views

To clarify the possible role of CD44 expression in ovarian tumour development and progression, an immunohistochemical investigation was undertaken of a series of 115 carcinomas, 32 tumours with low malignant potential (LMP), and 53 cystadenomas. A combination of the reverse transcription-polymerase